Professor Rutter’s research will continue to focus on luminal gastroenterology, in particular bowel cancer screening and surveillance. He will also be expanding his research into endoscopy quality and how this can be developed to improve outcomes for patients.
The institute’s vision is to facilitate collaborative and multidisciplinary research across the different research institutes within the Faculty of Medical Sciences, within the other faculties of Newcastle University, and across NHS partners.
It brings together expertise in basic biology, cancer biology, epidemiology and health services research, and clinical cancer research and care. It aims to increase the internal and external profile of cancer research in Newcastle and to bring different research groups and their complementary expertise from all our institutions together and build stronger teams to advance cancer therapy.
Newcastle University’s Institute of Cancer Research aims to bridge the different gaps that hinder rapid translation of new insights on fundamental cancer biology into its clinical application. Through Newcastle Cancer, researchers across Newcastle University and our NHS partners are developing strong links with the clinical and translational research programmes in the Northern Institute of Cancer Research (NICR).
Professor Matt Rutter said: “Newcastle University’s research facility is an incredibly valuable resource not only for the North East region but for cancer research nationally and internationally. It is a privilege to be involved with the institution and I look forward to deeper collaboration with the multidisciplinary team.”